ARK Investment Management
- Alexandra Urman
Alexandra “Ali” joined ARK as an Analyst on the Genomic Revolution strategy in February 2020. She focuses on gene editing, stem cell and novel immunotherapy technologies.
Org chart
Sign up to view 0 direct reports
Get started